Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics
Quantifying gene expression in individual cells can substantially improve our understanding about complex genetically engineered cell products such as chimeric antigen receptor (CAR) T cells. Here we designed a single-cell RNA sequencing (scRNA-seq) approach to monitor the delivery of a CD19-CAR gen...
Main Authors: | Filippos T. Charitidis, Elham Adabi, Frederic B. Thalheimer, Colin Clarke, Christian J. Buchholz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050121001571 |
Similar Items
-
Engineering switchable and programmable universal CARs for CAR T therapy
by: Delong Liu, et al.
Published: (2019-07-01) -
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells
by: Nicole Cordes, et al.
Published: (2021-06-01) -
Genetic Modification of T Cells
by: Richard A. Morgan, et al.
Published: (2016-04-01) -
A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines
by: Dina Schneider, et al.
Published: (2017-05-01) -
Physiological lentiviral vectors for the generation of improved CAR-T cells
by: María Tristán-Manzano, et al.
Published: (2022-06-01)